63 related articles for article (PubMed ID: 10597320)
1. Search for in vivo somatic mutations in the mitotic checkpoint gene, hMAD1, in human lung cancers.
Nomoto S; Haruki N; Takahashi T; Masuda A; Koshikawa T; Takahashi T; Fujii Y; Osada H; Takahashi T
Oncogene; 1999 Nov; 18(50):7180-3. PubMed ID: 10597320
[TBL] [Abstract][Full Text] [Related]
2. Identification of frequent impairment of the mitotic checkpoint and molecular analysis of the mitotic checkpoint genes, hsMAD2 and p55CDC, in human lung cancers.
Takahashi T; Haruki N; Nomoto S; Masuda A; Saji S; Osada H; Takahashi T
Oncogene; 1999 Jul; 18(30):4295-300. PubMed ID: 10439037
[TBL] [Abstract][Full Text] [Related]
3. Mutations in the mitotic check point gene, MAD1L1, in human cancers.
Tsukasaki K; Miller CW; Greenspun E; Eshaghian S; Kawabata H; Fujimoto T; Tomonaga M; Sawyers C; Said JW; Koeffler HP
Oncogene; 2001 May; 20(25):3301-5. PubMed ID: 11423979
[TBL] [Abstract][Full Text] [Related]
4. Genetic and epigenetic screening for gene alterations of the chromatin-remodeling factor, SMARCA4/BRG1, in lung tumors.
Medina PP; Carretero J; Fraga MF; Esteller M; Sidransky D; Sanchez-Cespedes M
Genes Chromosomes Cancer; 2004 Oct; 41(2):170-7. PubMed ID: 15287030
[TBL] [Abstract][Full Text] [Related]
5. Functional evaluation of missense variations in the human MAD1L1 and MAD2L1 genes and their impact on susceptibility to lung cancer.
Guo Y; Zhang X; Yang M; Miao X; Shi Y; Yao J; Tan W; Sun T; Zhao D; Yu D; Liu J; Lin D
J Med Genet; 2010 Sep; 47(9):616-22. PubMed ID: 20516147
[TBL] [Abstract][Full Text] [Related]
6. Inactivating mutations targeting the chfr mitotic checkpoint gene in human lung cancer.
Mariatos G; Bothos J; Zacharatos P; Summers MK; Scolnick DM; Kittas C; Halazonetis TD; Gorgoulis VG
Cancer Res; 2003 Nov; 63(21):7185-9. PubMed ID: 14612512
[TBL] [Abstract][Full Text] [Related]
7. Mitotic checkpoint locus MAD1L1 maps to human chromosome 7p22 and mouse chromosome 5.
Jin DY; Kozak CA; Pangilinan F; Spencer F; Green ED; Jeang KT
Genomics; 1999 Feb; 55(3):363-4. PubMed ID: 10049595
[No Abstract] [Full Text] [Related]
8. Somatic mutation of the hBUB1 mitotic checkpoint gene in primary lung cancer.
Gemma A; Seike M; Seike Y; Uematsu K; Hibino S; Kurimoto F; Yoshimura A; Shibuya M; Harris CC; Kudoh S
Genes Chromosomes Cancer; 2000 Nov; 29(3):213-8. PubMed ID: 10992296
[TBL] [Abstract][Full Text] [Related]
9. Reduced transcription of the RB2/p130 gene in human lung cancer.
Xue Jun H; Gemma A; Hosoya Y; Matsuda K; Nara M; Hosomi Y; Okano T; Kurimoto F; Seike M; Takenaka K; Yoshimura A; Toyota M; Kudoh S
Mol Carcinog; 2003 Nov; 38(3):124-9. PubMed ID: 14587097
[TBL] [Abstract][Full Text] [Related]
10. Aberrant hypermethylation of the CHFR prophase checkpoint gene in human lung cancers.
Mizuno K; Osada H; Konishi H; Tatematsu Y; Yatabe Y; Mitsudomi T; Fujii Y; Takahashi T
Oncogene; 2002 Apr; 21(15):2328-33. PubMed ID: 11948416
[TBL] [Abstract][Full Text] [Related]
11. Somatic mutations and genetic polymorphisms of the PPP1R3 gene in patients with several types of cancers.
Takakura S; Kohno T; Shimizu K; Ohwada S; Okamoto A; Yokota J
Oncogene; 2000 Feb; 19(6):836-40. PubMed ID: 10698503
[TBL] [Abstract][Full Text] [Related]
12. Genetic alteration of the beta-catenin gene (CTNNB1) in human lung cancer and malignant mesothelioma and identification of a new 3p21.3 homozygous deletion.
Shigemitsu K; Sekido Y; Usami N; Mori S; Sato M; Horio Y; Hasegawa Y; Bader SA; Gazdar AF; Minna JD; Hida T; Yoshioka H; Imaizumi M; Ueda Y; Takahashi M; Shimokata K
Oncogene; 2001 Jul; 20(31):4249-57. PubMed ID: 11464291
[TBL] [Abstract][Full Text] [Related]
13. Mutations and deletions of the CBP gene in human lung cancer.
Kishimoto M; Kohno T; Okudela K; Otsuka A; Sasaki H; Tanabe C; Sakiyama T; Hirama C; Kitabayashi I; Minna JD; Takenoshita S; Yokota J
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):512-9. PubMed ID: 15701835
[TBL] [Abstract][Full Text] [Related]
14. Infrequent mutations of the activating transcription factor-2 gene in human lung cancer, neuroblastoma and breast cancer.
Woo IS; Kohno T; Inoue K; Ishii S; Yokota J
Int J Oncol; 2002 Mar; 20(3):527-31. PubMed ID: 11836564
[TBL] [Abstract][Full Text] [Related]
15. Identification of frequent G(2) checkpoint impairment and a homozygous deletion of 14-3-3epsilon at 17p13.3 in small cell lung cancers.
Konishi H; Nakagawa T; Harano T; Mizuno K; Saito H; Masuda A; Matsuda H; Osada H; Takahashi T
Cancer Res; 2002 Jan; 62(1):271-6. PubMed ID: 11782387
[TBL] [Abstract][Full Text] [Related]
16. Frequent BRG1/SMARCA4-inactivating mutations in human lung cancer cell lines.
Medina PP; Romero OA; Kohno T; Montuenga LM; Pio R; Yokota J; Sanchez-Cespedes M
Hum Mutat; 2008 May; 29(5):617-22. PubMed ID: 18386774
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of mitotic checkpoint genes in breast cancer cells with chromosomal instability.
Yuan B; Xu Y; Woo JH; Wang Y; Bae YK; Yoon DS; Wersto RP; Tully E; Wilsbach K; Gabrielson E
Clin Cancer Res; 2006 Jan; 12(2):405-10. PubMed ID: 16428479
[TBL] [Abstract][Full Text] [Related]
18. c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions.
Ma PC; Kijima T; Maulik G; Fox EA; Sattler M; Griffin JD; Johnson BE; Salgia R
Cancer Res; 2003 Oct; 63(19):6272-81. PubMed ID: 14559814
[TBL] [Abstract][Full Text] [Related]
19. Frequent mutations of human Mad2, but not Bub1, in gastric cancers cause defective mitotic spindle checkpoint.
Kim HS; Park KH; Kim SA; Wen J; Park SW; Park B; Gham CW; Hyung WJ; Noh SH; Kim HK; Song SY
Mutat Res; 2005 Oct; 578(1-2):187-201. PubMed ID: 16112690
[TBL] [Abstract][Full Text] [Related]
20. Mutational analysis of the transforming growth factor beta receptor type II gene in hereditary nonpolyposis colorectal cancer and early-onset colorectal cancer patients.
Shin KH; Park YJ; Park JG
Clin Cancer Res; 2000 Feb; 6(2):536-40. PubMed ID: 10690536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
